Free Trial
OTCMKTS:GLAE

Imation (GLAE) Stock Price, News & Analysis

Imation logo
$30.00 0.00 (0.00%)
As of 08/8/2025

About Imation Stock (OTCMKTS:GLAE)

Key Stats

Today's Range
$30.00
$30.00
50-Day Range
$25.00
$30.00
52-Week Range
$20.00
$32.00
Volume
N/A
Average Volume
N/A
Market Capitalization
$900 thousand
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive GLAE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Imation and its competitors with MarketBeat's FREE daily newsletter.

GLAE Stock News Headlines

A new rule goes live in July — and the banks are quietly crushing it
A little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Street and the Big Banks… It gives them the green light to treat a certain tangible asset as equivalent to cold, hard cash. Not stocks. Not real estate. And definitely not the U.S. dollar. We're talking about something they don't want you to notice — because the fewer people who act on this, the better it is for them.
Seafood Salad Stuffed Rainbow Peppers
See More Headlines

GLAE Stock Analysis - Frequently Asked Questions

Imation's stock was trading at $32.00 on January 1st, 2025. Since then, GLAE stock has decreased by 6.3% and is now trading at $30.00.

Imation Corporation (OTCMKTS:GLAE) posted its earnings results on Tuesday, August, 14th. The company reported ($0.39) EPS for the quarter. The firm had revenue of $8 million for the quarter.

Imation shares reverse split before market open on Wednesday, February 22nd 2017.The 1-10 reverse split was announced on Friday, February 10th 2017. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, February 21st 2017. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

Shares of GLAE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Imation investors own include Arbutus Biopharma (ABUS), AcelRx Pharmaceuticals (ACRX), Allena Pharmaceuticals (ALNA), Ampio Pharmaceuticals (AMPE), Amira Nature Foods (ANFI), Ampliphi Biosciences (APHB) and Athersys (ATHX).

Company Calendar

Last Earnings
8/14/2018
Today
8/09/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Finance
Industry
FIN - MISC SVCS
Sub-Industry
Trading
Current Symbol
OTCMKTS:GLAE
Previous Symbol
NYSE:GLA
CIK
1014111
Employees
5
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
$100 thousand
Price / Sales
9.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
30,000
Free Float
26,000
Market Cap
$900 thousand
Optionable
Not Optionable
Beta
6.27
The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

This page (OTCMKTS:GLAE) was last updated on 8/9/2025 by MarketBeat.com Staff
From Our Partners